Health Catalyst, Inc. (HCAT) Cash Flow Statement

The negative operating cash-to-net-income ratio across most quarters indicates that reported losses are substantially driven by non-cash items such as impairments or other accruals, which is consistent with the prior finding of non-operating charges amplifying losses. Quarters such as 2025Q2 and 2024Q3 show the reverse pattern, where operating cash flow diverged from net income in ways that warrant further investigation into the timing of working capital and accrual reversals. Investors should monitor whether these non-cash charges recur, since persistent divergence would reduce confidence in earnings quality.

The alternation between small positive and negative FCF margins suggests the business is not yet generating reliable free cash flow, even though it occasionally produces spikes such as 2026Q1 at $13.6 million. The latest quarter's negative FCF margin of 6.9 percent appears to reverse the prior quarter's strength, which may indicate that working capital timing rather than structural improvement drove the recent result. Stable, repeatable FCF generation is not yet evident in the reported data.

The low baseline CapEx relative to revenue implies a capital-light model, yet the periodic spikes suggest discrete investment projects rather than recurring maintenance spending. Depreciation and amortization of roughly $10 to $13 million per quarter exceeds most CapEx figures, which may indicate the asset base is being consumed faster than it is being replaced. This pattern warrants further investigation into whether the spikes reflect capitalized development or infrastructure needs.

The absence of dividends combined with negative or marginal free cash flow suggests capital is not being returned to shareholders, which is consistent with a company still prioritizing investment or balance sheet flexibility. The sizable acquisition outflows in 2024 and 2025, relative to modest operating cash generation, may indicate that growth has been pursued through purchases rather than organic cash build. Investors should monitor whether acquired businesses begin contributing to operating cash flow.

A cumulative gap of this magnitude suggests that reported losses have not been matched by equivalent cash outflows, pointing toward substantial non-cash charges that may be recurring. This pattern is consistent with the prior finding that non-operating items amplify net losses beyond the operating loss level. The data does not fully support a conclusion that the business is structurally cash-burning, but the divergence itself warrants close scrutiny of impairment and accrual practices.